Patents by Inventor Hollie Jaine JACKSON

Hollie Jaine JACKSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-1 immune modulating agents
    Patent number: 11136392
    Abstract: The present application provides anti-PD-1 antigen-binding proteins or a fragment thereof, as well as nucleic acids encoding anti-PD-1 antigen-binding proteins or CAR T cells expressing such antigen-binding protein or fragment. Also provided are methods of regulating T cells or treating patients using such constructs or cells.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: October 5, 2021
    Assignees: MEMORIAL SLOAN-KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: Renier J. Brentjens, Hollie Jaine Jackson, Cheng Liu
  • PD-1 immune modulating agents
    Patent number: 11104733
    Abstract: The present application provides anti-PD-1 antigen-binding proteins or a fragment thereof, as well as nucleic acids encoding anti-PD-1 antigen-binding proteins or CAR T cells expressing such antigen-binding protein or fragment. Also provided are methods of regulating T cells or treating patients using such constructs or cells.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: August 31, 2021
    Assignees: MEMORIAL SLOAN-KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: Renier J. Brentjens, Hollie Jaine Jackson, Cheng Liu
  • NOVEL PD-1 IMMUNE MODULATING AGENTS
    Publication number: 20180127502
    Abstract: The present application provides anti-PD-1 antigen-binding proteins or a fragment thereof, as well as nucleic acids encoding anti-PD-1 antigen-binding proteins or CAR T cells expressing such antigen-binding protein or fragment. Also provided are methods of regulating T cells or treating patients using such constructs or cells.
    Type: Application
    Filed: December 20, 2017
    Publication date: May 10, 2018
    Applicants: MEMORIAL SLOAN-KETTERING CANCER CENTER, EUREKA THERAPEUTICS, INC.
    Inventors: Renier J. BRENTJENS, Hollie Jaine JACKSON, Cheng LIU